About us

Polpharma Biologics is the trusted developer & manufacturer of biosimilars.

We are an international company, with integrated operations in the European Union, passionate about broadening access to biological medicines.

We care about global sustainability, speed to market, scientific rigour - in compliance with the highest quality requirements.

We care that our partners and our people enjoy working with us.

Our history

We care about creating quality biologics with passion

We are passionate about providing safe and effective biosimilars to patients.
We work with dedication to find innovative solutions.
We anticipate potential issues before they arise, always ensuring high quality & compliant outcomes.

We care about delivering on our commitments

We are committed to positive outcomes and delivering projects on time and budget.
We manage programs diligently and communicate clearly and concisely.
We are self-motivated & proactive to reach the end result.

We care about being respectful and transparent

We are open and honest; integrity is in our DNA.
We value everyone equally and treat others with respect.
We collaborate and rely on each other.

Code of Conduct

This Code of Conduct is prepared and implemented in the Polpharma Biologics Group (PB) to ensure we conduct our business to the highest ethical standards.
This document forms the foundation of our compliance system.
It is designed and implemented to ensure that our values are implemented comprehensively and in good faith.

This Code has been constructed in accordance with applicable laws, business standards and health authorities’ compliance requirements adopted by the biotechnology industry.

Download document

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

Gdańsk

Our FDA-approved Gdańsk site includes mammalian and microbial R&D and GMP manufacturing facilities for mid-scale production.

Warsaw

Our Warsaw-Duchnice site is one of the largest commercial mammalian manufacturing sites in the region.

Utrecht

Our Utrecht site is home to our industry-leading proprietary cell line development platform.

Our sites

Learn more

Gdańsk

Our FDA-approved Gdańsk site includes mammalian and microbial R&D and GMP manufacturing facilities for mid-scale production.
Warsaw

Our Warsaw-Duchnice site is one of the largest commercial mammalian manufacturing sites in the region.
Utrecht

Our Utrecht site is home to our industry-leading proprietary cell line development platform.

Learn more

Innovation in Poland

Over the last decade Polpharma Biologics has created a biotechnology sector almost from scratch in Poland. We consistently invest, not only laboratories and production lines, but also in know-how, driving growth of highly-qualified jobs, as well as developing cooperation between science and business.

Learn more

Industry leading team

At Polpharma Biologics, our commitment to excellence begins at the top. With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals. Our international management team brings both knowledge and passion to every project.

Learn more